免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Viatrac 14 Plus 頸動脈擴張針管

K 號:K221057 · 2022-05-05

決定日期2022-05-05
產品代碼LIT
諮詢委員會履歷
決定相當於

器材摘要

Viatrac 14 Plus Peripheral Dilatation Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Vascular. It received FDA 510(k) clearance on 2022-05-05 under 510(k) number K221057. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Viatrac 14 Plus Peripheral Dilatation Catheter?

Viatrac 14 Plus Peripheral Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2022-05-05. The listed applicant is Abbott Vascular. The 510(k) number is K221057.

When did Viatrac 14 Plus Peripheral Dilatation Catheter receive FDA 510(k) clearance?

Viatrac 14 Plus Peripheral Dilatation Catheter received FDA 510(k) clearance on 2022-05-05, under 510(k) number K221057.

Who is the listed applicant for Viatrac 14 Plus Peripheral Dilatation Catheter?

The FDA 510(k) record lists Abbott Vascular as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Viatrac 14 Plus Peripheral Dilatation Catheter?

The FDA product code for Viatrac 14 Plus Peripheral Dilatation Catheter is LIT.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Abbott Vascular 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 11 項裝置 →

相關器械(代碼:LIT)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑